Population Pharmacokinetic Analysis of Ledipasvir
(GS-5885) in Healthy and Hepatitis C Virus-Infected Subjects
Reported by Jules Levin
15th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy, May 19-21, 2014, Washington, DC
Brian Kirby,1 Hanbin Li,2 Brian P. Kearney,1 and Anita Mathias1
1Gilead Sciences, Inc., Foster City, California; 2Quantitative Solutions, Inc., Menlo Park, California
